Rhopressa — Medica
reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Preferred products
- generic bimatoprost 0.03% ophthalmic solution
- generic latanoprost 0.005% ophthalmic solution
- generic travoprost 0.004% ophthalmic solution
Initial criteria
- Patient has tried one Step 1 Product (generic bimatoprost 0.03% ophthalmic solution, generic latanoprost 0.005% ophthalmic solution, or generic travoprost 0.004% ophthalmic solution); OR
- Patient has a known benzalkonium chloride (BAK) sensitivity AND a known sensitivity to other ophthalmic preservatives (approve Iyuzeh, Xelpros, or Zioptan only)
Approval duration
1 year